Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria
Joaquín Miguel Pellegrini, … , Sylvie Mémet, Jean-Pierre Gorvel
Joaquín Miguel Pellegrini, … , Sylvie Mémet, Jean-Pierre Gorvel
Published April 15, 2025
Citation Information: J Clin Invest. 2025;135(8):e182467. https://doi.org/10.1172/JCI182467.
View: Text | PDF
Research Article Immunology Infectious disease Microbiology

SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria

  • Text
  • PDF
Abstract

Plasmacytoid dendritic cells (pDCs), professional type I IFN–producing cells, have been implicated in host responses against bacterial infections. However, their role in host defense is debated, and the operating molecular mechanisms are unknown. Certain signaling lymphocyte activation molecule family (SLAMF) members act as microbial sensors and modulate immune functions in response to infection. Here, human blood transcriptomic analyses reveal the involvement of SLAMF7 and SLAMF8 in many infectious diseases, with elevated levels associated with type I IFN responses in salmonellosis and brucellosis patients. We further identify SLAMF7 and SLAMF8 as key regulators of human pDC function. They activate pDC maturation and cytokine production during infection with bacteria that induce acute (Salmonella) or chronic (Brucella) inflammation. SLAMF7 and SLAMF8 signal through NF-κB, IRF7, and STAT-1, and limit mitochondrial ROS accumulation upon Salmonella infection. Remarkably, this SLAMF7/8-dependent control of mitochondrial ROS levels favors bacterial persistence and NF-κB activation. Overall, our results unravel essential shared multifaceted roles of SLAMF7 and SLAMF8 in finely tuning human pDC responses to intracellular bacterial infections with potential for future diagnostic and therapeutic applications.

Authors

Joaquín Miguel Pellegrini, Anne Keriel, Laurent Gorvel, Sean Hanniffy, Vilma Arce-Gorvel, Mile Bosilkovski, Javier Solera, Stéphane Méresse, Sylvie Mémet, Jean-Pierre Gorvel

×

Figure 2

Blood transcriptomic signatures reveal the participation of SLAMF7 and SLAMF8 in salmonellosis.

Options: View larger image (or click on image) Download as PowerPoint
Blood transcriptomic signatures reveal the participation of SLAMF7 and S...
(A) SLAMF7 and SLAMF8 normalized counts obtained by transcriptomic profiling analysis from whole-blood samples from a first cohort (GSE113866) composed of HD (n = 68, gray) controls and enteric fever patients with positive cultures for Salmonella enterica Typhi (ST; n = 19, dark green) or Salmonella enterica Paratyphi (SPT; n = 12, light green). Significant differences are shown (multiple-comparison Kruskal-Wallis test followed by post hoc Dunn’s test). ****P < 0.0001. (B) Volcano plot showing differentially expressed genes between HDs and salmonellosis patients from the first cohort (upregulated, red; and downregulated, cyan). (C) Correlation between SLAMF7 and SLAMF8 RNA counts across all groups of individuals, i.e., HDs (grays, n = 47) and patients with suspected enteric fever (n = 71, yellow) or culture-confirmed enteric fever (n = 30, green). Non-parametric Spearman’s correlation test. (D and E) “SLAMF” refers to SLAMF7 and SLAMF8. (D) SLAMF7 and SLAMF8 normalized counts obtained by transcriptomic profiling analysis from whole-blood samples from a second cohort (GSE69529) composed of HD (n = 35, gray) controls and age-matched patients with Salmonella gastroenteritis (n = 36, green). Multiple-comparison Kruskal-Wallis test followed by post hoc Dunn’s test. *P < 0.05; **P < 0.01. (E) Heatmap showing type I IFN module gene expression from whole-blood RNA-Seq data analysis of the second cohort with HDs (n = 35, gray) and patients with Salmonella gastroenteritis categorized according to their SLAMF7 and SLAMF8 expression in SLAMFhi (n = 15, dark red) and SLAMFlo (n = 26, turquoise) individuals.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts